Anderson Jolen
Known title: Senior Exec VPCIK: 0001786243
Associated companies
Transaction History
| BNY | ▼ Sell | Tax Withholding | 7,411 | $333K | 7/30/2023 | View on chart |
| BNY | ▲ Buy | Grant | 8,251 | $0 | 2/24/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 4,564 | $230K | 2/24/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 2,693 | $139K | 2/15/2023 | View on chart |
| BNY | ▲ Buy | Grant | 26,028 | $0 | 2/13/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 594 | $31K | 2/10/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 4,071 | $209K | 2/10/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 2,687 | $139K | 2/8/2023 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 1,295 | $50K | 10/1/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 594 | $38K | 2/10/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 2,651 | $169K | 2/8/2022 | View on chart |
| BNY | ▲ Buy | Grant | 15,772 | $0 | 2/7/2022 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 1,599 | $91K | 11/19/2021 | View on chart |
| BNY | ▼ Sell | Tax Withholding | 1,075 | $57K | 10/1/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
BNY Q3 Earnings Show Margin Gains and Raised Outlook
Bank of New York Mellon reported third-quarter results that highlighted margin improvements and a raised outlook, with a focus on AI initiatives. While the market reaction was muted, analysts noted the earnings beat. One firm maintained its stance but lowered its price target to $165, reflecting a cautious view despite the positive fundamentals.
BNY Q3 Earnings Show Margin Gains and Raised Outlook. Bank of New York Mellon reported third-quarter results that highlighted margin improvements and a raised outlook, with a focus on AI initiatives. While the market reaction was muted, analysts noted the earnings beat. One firm maintained its stance but lowered its price target to $165, reflecting a cautious view despite the positive fundamentals.